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The nonstructural protein NS3 of the hepatitis C virus (HCV) is indispensable for virus replication and a multifunctional
enzyme that contains three catalytic activities such as serine protease, helicase, and NTPase. Here, we demonstrated that
the internal cleavage of the HCV NS3 protein occurs in various mammalian cells such as HepG2, COS-7, and NIH3T3. As is
observed for the internal cleavage mechanism of the NS3 protein of dengue virus 2, the internal processing of HCV NS3
protein was catalyzed by the active NS3 serine protease and NS4A, but not NS3 alone. From the data acquired from
extensive site-directed mutagenesis, we observed that the NS3 protein was internally cleaved at two different sites,
FCH1395uS1396KK and IPT1428uS1429GD, within RNA helicase domain. The internal cleavage of NS3 protein by NS34A protease
was also confirmed in a different isolate of HCV-1b strain. In addition, in vitro transforming assays demonstrated that the
internal cleavage product of NS3, NS3a-1, appeared to have higher oncogenic potential than does intact NS3. Taken together,
our results suggest that the internal cleavage of NS3 may be associated with the replication and oncogenesis of HCV. © 2000
Academic Press
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pINTRODUCTION
Hepatitis C virus (HCV) is a member of the Flaviviridae
family and accounts for the majority of posttransfusion
and sporadic non-A, non-B viral hepatitis worldwide
(Choo et al., 1989). The persistence of HCV in infected
humans leads to cirrhosis and hepatocellular carcinoma
(Kiyosawa et al., 1990). The viral genome is a single-
stranded, positive-sense RNA of approximately 9.5 kb,
which encodes a polyprotein precursor. This polyprotein
is cleaved by host-signal peptidase and two virally en-
coded proteases to generate viral structural (core, E1,
and E2/p7) and nonstructural proteins (NS2, NS3, NS4A,
NS4B, NS5A, and NS5B), respectively (Hijikata et al.,
1991).
The viral serine protease resides in the amino-terminal
half of the NS3 protein, which, with NS4A as a cofactor,
cleaves NS3/4A, NS4A/4B, NS4B/5A, and NS5A/5B junc-
tions (Bartenschlager et al., 1993; Tomei et al., 1993). In
ddition to enzymatic activity, it has been reported that
he 59 region of HCV NS3 transforms NIH3T3 cells (Saka-
uro et al., 1995) and suppresses actinomycin-D-in-
uced apoptosis of NIH3T3 cells (Fujita et al., 1996),
uggesting that the NS3 may play important roles on
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132athogenic effects in host cells infected by HCV. Further-
ore, the carboxyl-terminal half of the NS3 protein has a
ucleotide triphosphate-RNA helicase activity (Kim et al.,
995). Therefore, NS3 is a multifunctional protein that
ontributes to virus replication.
It was recently reported that the NS3 protein is inter-
ally cleaved within an RNA helicase sequence motif in
nsect and 293T cells not by NS3 protease, but by a
ellular protease (Shoji et al., 1999). In contrast, we found
hat the internal processing of the NS3 protein is depen-
ent on the NS3 protease activity in a variety of mam-
alian cell types. Moreover, internal cleavage of NS3
as shown to require the presence of NS4A cofactor. In
ddition, we demonstrated that the internal cleavage
roduct of NS3 has higher oncogenic potential than does
he intact NS3 protein and further increases the onco-
enic activity of the HCV core. These results suggest that
he internal cleavage product of NS3 may play a role in
he replication and oncogenesis of HCV.
RESULTS AND DISCUSSION
nternal processing of HCV NS3 by the activity of
S34A serine protease
To express the NS3 (amino acids [aa] 1019–1657),
S34A (aa 1019–1711), and NS3-NS4-NS5 (aa 1019–3010)
oding region, COS-7 cells were transfected with pNS3,
NS34A, and pNS345 plasmids, respectively, which were
erived from HCV-1b (JS strain). By immunoprecipitation
sing anti-NS3 and anti-NS4 positive patients’ sera, the
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133INTERNAL CLEAVAGE OF HCV NS3expression and processing pattern of the NS3 were
investigated. As a result, we found that the NS3 protein
expressed from pNS34A and pNS345, but not pNS3, was
processed to generate two different products, which
were designated as NS3a-1 (44 kDa) and NS3a-2 (41
kDa) (Fig. 1A, lanes 2–4). NS3a-1 and NS3a-2 bands in
lane 4 seemed fainter than those seen in lane 3. How-
ever, the NS3 band was also slightly fainter than that in
lane 3, indicating that this different observation between
lane 3 and lane 4 was the result of the difference of the
expression level of NS3 protein derived from pNS34A- or
pNS345-expression plasmids. Therefore, these results
indicate that internal cleavage of NS3 occurs in NS345
polyprotein as well as NS34A itself and that NS4A is
indispensable for internal processing of NS3. In pNS345
transfectants, NS5A and NS5B protein were not detected
(lane 4), which is the result of low anti-NS5 antibody titer.
A faint band reactive to the anti-NS3 positive sera at the
FIG. 1. The internal cleavage of HCV NS3 protein requires both NS4
(lane 1), pNS3 (lane 2), pNS34A (lane 3), or pNS345 (lane 4) were lab
uman sera and electrophoresed through an SDS–12% polyarylamide
ndicate the full-size NS3 protein (72 kDa) (lanes 3 and 4), its cleavage
rotein (26 kDa) (lane 4). (B) pCI-neo- (lane1), pNS3- (lane 2), or pNS34A
b. (C) NIH3T3 transfected with pNS4A (lane 1), pNS3 (lane 2), pNS34A
sing antiprotease Ab. (D) HepG2 cells transfected with pCI-neo
mmunoprecipitated with antiprotease Ab. The unprocessed-NS34A fusi
S3a-1 (44 kDa) and NS3a-2 (41 kDa) are indicated by arrows.position moving slightly slower than NS3a-1 could be
detectable (lanes 3 and 4), implying that this band may
a
Nalso correspond to one among internal cleavage prod-
ucts. However, we focused on the characterization of two
different products, NS3a-1 and NS3a-2, because of its
amount of very low level compared to that of NS3a-1 or
NS3a-2.
To investigate whether NS3a-1 and NS3a-2 corre-
sponded either to the N-terminal or the C-terminal por-
tion of NS3, COS-7 cells transfected with pNS3 and
pNS34A were immunoprecipitated with antibody recog-
nizing the serine protease domain of NS3 (antiprotease
antibody). The polyclonal antiprotease antibody was
raised against the recombinant serine protease domain
of NS3 (aa 1027–1218), expressed, and purified in Esch-
richia coli. Both NS3a-1 and NS3a-2 proteins were de-
ected with antiprotease antibody (Fig. 1B, lane 3), indi-
ating that these cleavage products correspond to the
-terminal portion of the NS3 protein.
To determine whether the internal cleavage of NS3
NS3 serine protease activity. (A) COS-7 cells transfected with pCI-neo
ith [35S]methionine and immunoprecipitated with pooled HCV-infected
e molecular sizes (kDa) are indicated on the left. Arrows on the right
cts, NS3a-1 (44 kDa) and NS3a-2 (41 kDa) (lanes 3 and 4), and NS4B
3)-transfected COS-7 cells were immunoprecipitated with antiprotease
3), or pNS3 and pNS4A (lane 4) were analyzed by immunoprecipitation
), pNS3 (lane 2), pNS34A (lane 3), or pNS34A-M1 (lane 4) were
ein (80 kDa), full-size NS3 protein (72 kDa), and its processed products,A and
eled w
gel. Th
produ
(lane
(lane
(lane 1lso occurs when NS4A proteins were provided in trans,
IH3T3 cells were cotransfected with both pNS3 and
4
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134 YANG ET AL.pNS4A expression plasmid. The transfected cells were
analyzed by immunoprecipitation with antiprotease anti-
body. When NS4A were provided in trans (Fig. 1C, lane
), the internal cleavage of NS3 occurred at a slightly
ower efficiency than that derived from pNS34A (Fig. 1C,
ane 3). It has been reported that the structure of the
atalytic site of the NS34A protease is significantly dif-
erent from that of the NS3 protease (NS3pro), indicating
hat the binding of NS4A to NS3 induces tertiary structure
hanges, resulting in accelerated enzyme reactions
Steinkuhler et al., 1996; Kwong et al., 1998). It is therefore
ossible that NS4A induces the conformational change
f the catalytic site of NS3, which is required for the
nternal cleavage by NS3pro.
We next tested whether the serine protease activity of
HCV NS3 is necessary for the internal processing of the
NS3 protein. It was reported that the activity of NS3
protease requires a catalytic triad: His1083, Asp1107, and
er1165 (Bazan et al., 1989). To inactivate NS3 serine
rotease, Ser1164 and Ser1165 in the NS3 region were
utated to Ala and Ala by site-directed mutagenesis and
he resulting plasmid, pNS34A-M1, was transfected to
uman hepatoma HepG2 cells. The unprocessed-NS34A
usion protein (80 kDa), but not NS3a-1 and NS3a-2, was
etected by immunoprecipitation with antiprotease anti-
odies (Fig. 1D, lane 4), indicating that serine protease
ctivity is required for internal cleavage of NS3. The
bservation that NS3 and NS34A-M1 protein were not
nternally cleaved by themselves indicates that there is
o cellular protease capable of internal cleavage of NS3.
hese results indicate that the internal cleavage of HCV
S3 protein requires not only NS4A as a cofactor but
lso the activity of NS3 serine protease. However, there
s still another possibility that NS34A protease may ac-
ivate a cellular protease and the activated protease is
esponsible for the internal cleavage of NS3.
Our observations are similar to the internal cleavage
f NS3 derived from dengue virus 2 (DEN-2), a member
f the Falviviridae family. The internal cleavage of NS3 in
DEN-2 is dependent on the serine protease activity in the
NS3 region as well as NS2B as a cofactor (Falgout et al.,
1991; Arias et al., 1993; Keng et al., 1997).
In contrast to these results, it was recently reported
that the internal processing of the NS3 protein occurred
within the RNA helicase sequence motif (amino acid
position, QRR1488uGRT) in insect cells and 293T cells, and
s mediated by a cellular protease (Shoji et al., 1999).
hese conflicting observations may stem from the fol-
owing reasons: (1) the internal processing of the NS3 by
ellular protease occurs only in specific cell types, such
s insect cells and 293T cells; and (2) the products of
S3 cleaved by cellular protease may be unstable in
OS-7, NIH3T3, and HepG2 cells.
As shown in Fig. 1A, we could not detect the C-erminal counterparts (proteins of 28 and 31 kDa) of
S3a-1 (44 kDa) and NS3a-2 (41 kDa) by immunoprecipi- tation. Pulse-chase analysis indicated that NS3a-1 and
S3a-2 were stable during a 120-min chase period, but
hat the C-terminal cleavage products of these proteins
ere not detectable (data not shown). It has been pre-
iously shown that the C-terminal cleavage product of
S3 derived from DEN-2 virus was not detected at the
0-min chase in transfected cells, although it was faintly
etectable in a 10-min chase (Keng et al., 1997). Thus, it
s likely that the C-terminal cleavage products of HCV
S3 are too unstable to be detected by using standard
rocedures. Alternatively, it is also possible that the fail-
re to detect the C-terminal moieties of the NS3 may
esult from the used antibodies with low reactivity to the
hort C-terminal piece of the NS3 protein.
utational analysis of the putative cleavage sites of
S3
Immunoprecipitation data using antiprotease antibody
ed us to infer that the internal cleavage of NS3 protein
ccurred at two different sites, and that the NS3a-1 and
S3a-2 proteins belonged to the N-terminal portion of
S3. In DEN-2 virus, the processing events by the NS3
rotease (NS3pro) occurred in regions containing a diba-
sic amino acid motif (Lys or Arg) at the P1 and P2
positions, followed by small branched residues (Ser, Ala,
or Gly) at the P19 position (Falgout et al., 1991; Arias et al.,
993). According to the nomenclature of Berger and
chechter (1970), P1 and P19 are designated as the
arboxy- and amino-terminus generated by cleavage of
he peptide bond, respectively. Since the internal cleav-
ge of NS3 proteins by the NS2B/NS3 complex of DEN-2
as demonstrated to occur at the site RR458uG459R, which
corresponds to the conserved cleavage site of DEN-2
NS3pro, it is likely that the internal cleavage of HCV NS3
rotein also occurs in regions that show sequence ho-
ology with the conserved cleavage sites of HCV NS3pro.
It was known that conserved cleavage sites of NS3pro of
HCV consist of an acidic residue at P6, threonine or
cysteine at P1, and serine or alanine at P19 (Komoda et
l., 1994; Steinkuhler et al., 1996). On the basis of either
he sequence homology of cleavage sites of NS3pro or the
size of NS3a-1 and NS3a-2, we have constructed 14
NS34A point-mutants (from pNS34A-M2 to pNS34A-M15)
(Fig. 2A). To generate a restriction enzyme site and com-
pletely block the internal cleavage, two amino acids at
putative P1 and P19 residues were changed to either Ala,
Cys, or to Pro, Gly (Fig. 2A). When NIH3T3 cells were
transfected with these NS34A mutants, the internal
cleavage of NS3 was blocked only in cells transfected
with pNS34A-M5 and pNS34A-M13 (Fig. 2A). NS3a-2 was
not detected in cells transfected with pNS34A-M5
(H1395uS1396 3 PuG), while full-size NS3 and NS3a-1 pro-
teins were detected (Fig. 3A, lane 4). In addition, NS3a-1
1428 1429was not detected in pNS34A-M13 (T uS 3 AuS)
ransfected cells (Fig. 3A, lane 5). These results indicate
w
l cleava
135INTERNAL CLEAVAGE OF HCV NS3that the internal cleavage sites of NS3 by the NS34A
protease are located at amino acid residues 1395/1396
and 1428/1429, which are located in the RNA helicase
domain (Fig. 2B). When the internal cleavage site (DVS-
VIPT1428/S1429) was compared with the conserved cleav-
age sites of NS3pro, amino acid residues of P1 and P19
positions (Thr and Ser) exactly coincided with those of
the cleavage site of NS3pro. Acidic residue (Asp), how-
ever, is found at the P7 position rather than at the P6
position. Analysis of the other internal cleavage site
(RHLIFCH1395/S1396) showed that amino acid residue (Ser)
of P19 position is coincided, but amino acid residues at
P1, P6 positions are different from those of the conserved
cleavage sites of NS3pro. Since it was demonstrated that
cleavage sites of NS3pro have high flexibility for substitu-
FIG. 2. (A) The names of NS3-, NS4A-, NS34A-, or mutant NS34A-en
NS34A mutants are generated to analyze the internal cleavage sites of
amino acids are indicated. The internal cleavage activity of each mutan
here 1 5 cleavage and 2 5 no detectable cleavage. (B) Schematic r
protease-mediated cleavage sites. Curved arrows indicate the interna
indicate the positions of amino acids.tion at P1, P19, and P6 positions (Kolykhalov et al., 1994;
Bartenschlager et al., 1995), it is not surprising that the
h
Dinternal cleavage sites of NS3 identified in this study are
somewhat different from the conserved cleavage sites.
Recently, Kang and Oh (1998) have determined the X-ray
crystallographic structure of the helicase domain of the
NS3 protein. According to these data, the internal cleav-
age sites of NS3 are exposed on the surface of an
arginine-rich domain in the helicase region, suggesting
that internal cleavages could occur as a favorable inter-
action with the active site of the NS3 protease (personal
communication).
To investigate whether these internal cleavage sites
were conserved in other genotypes of HCV, the potential
internal cleavage sites in various HCV genotypes and
isolates were analyzed. A sequence alignment indicated
that the internal cleavage site, HLIFCH1395/S1396 was
plasmids are shown on the left. Using site-directed mutagenesis, 15
V NS3 protein. The positions of amino acid substitution and converted
two different sites, H1395uS1396 and T1428uS1429, is indicated with 1 or 2,
tation of nonstructural region of HCV. Vertical arrows indicate the NS3
ge sites mediated by the NS34A protease. The numbers on the barscoding
the HC
t at the
epresenighly conserved in most HCV genotypes, whereas the
VSVIPT1428/S1429 site was less conserved (Fig. 3B). To
J
u
et al.,
136 YANG ET AL.determine whether the internal processing of NS3 pro-
tein also occurred in other isolates of HCV, we con-
structed pNS34A-K derived from the PCR-amplified
NS34A region of HCV-1b (K isolate) (Cho et al., 1993),
which has 92.5% amino acid sequence homology with
pNS34A within the NS3 region and possesses putative
internal cleavage sites (Fig. 3B). As expected, NS3a-1
and NS3a-2 were also detected in NIH3T3 cells trans-
fected with pNS34A-K (Fig. 3A, lane 6), indicating that the
internal processing of the NS3 protein also occurred in
another isolate of HCV 1b strain. However, a processing
of NS3 derived from isolate K seems to be a little less
efficient than that from isolate JS (Fig. 3A, lanes 3 and 6),
presumably resulting from the difference in amino acid
sequence between them.
Shoji et al. (1999) could not detect NS3a-1 and NS3a-2
proteins in 293T cells and insect cells, which may stem
from the following reasons: (1) since the internal cleav-
age of NS3 protein was analyzed without NS4A in 293T
cells, NS3a-1 and NS3a-2 might not be generated from
NS3 protein; and (2) when full-length HCV cDNA derived
from HCV 1b strain (NIH J1) was expressed in insect
FIG. 3. (A) Analysis of the putative cleavage sites in the NS3 protein
3), pNS34A-M5 (lane 4), pNS34A-M13 (lane 5), or pNS34A-K (lane 6) we
through an SDS–12% polyarylamide gel. The full-size NS3 protein as w
alignment of the internal cleavage site in NS3 of various HCV genotype
HCV NS3. Arrows on the top indicate the putative internal cleavage site
HCV isolates used for alignments are as follows: JS (Sugiyama et al., 1
Australian (Trowbridge et al., 1998), JT (Tanaka et al., 1992), L2 (Cho et a
(Hayashi et al., 1993), HCV-1 (Choo et al., 1991), HC-J6 (Okamoto et
(Sakamoto et al., 1994), TrkJ (Chayama et al., 1994), ED43 (Chamberlain
al., 1997).cells, amino acid of P1 position in the internal cleavage
site (DVSVIPT1428/S1429) is not threonine but alanine in NIH1 isolate (Fig. 3B). From our immunoprecipitation data
sing site-directed mutant, pNS34A-M13 (Thr 3 Ala at
P1 position) (Fig. 3A), it is reasonable to assume that
NS3a-1 will not be generated in NIH J1 isolate. Although
the other internal cleavage site (HLIFCH1395/S1396) is con-
served in NIH J1 isolate, it is likely that the internal
cleavage of NS3 protein by NS34A protease may occur
inefficiently in insect cells.
Oncogenic potential of NS3a-1
Although it was previously reported that the artificially
truncated N-terminal portion (aa 1027–1281) of the HCV
NS3 protein transforms NIH3T3 cells (Sakamuro et al.,
1995), the oncogenic potential of full-length NS3 and the
naturally truncated form of NS3 has not been addressed.
To express the NS3a-1 coding region, NS3a-1 was am-
plified by PCR with pNS3 plasmid, and NS3a-1-expres-
sion plasmid was designated as pNS3a-1. The size of
protein expressed from pNS3a-1 in Rat-1 cells corre-
sponded to the size of NS3a-1 derived from autoprote-
olysis of the NS3 protein and the expression level of
3 cells transfected with pCI-neo (lane 1), pNS3 (lane 2), pNS34A (lane
munoprecipitated with an antiprotease antibody and electrophoresed
S3a-1 and NS3a-2 are indicated by arrows on the right. (B) Sequence
numbers on the sequence indicate the position of the amino acids of
3. A dot indicates a residue that is identical to that in HCV 1b (JS). The
(Cho et al., 1993), JK1 (Honda et al., 1992), HC-C2 (Wang et al., 1993),
, NIHJ1 (Aizaki et al., 1998), BK (Takamizawa et al., 1991), HCV-N variant
1), HC-J8G (Okamoto et al., 1992), BEBE1 (Nakao et al., 1996), NZL1
1997a), EUH1480 (Chamberlain et al., 1997b), and EUHK22 (Adams et. NIH3T
re imm
ell as N
s. The
s in NS
997), K
l., 1995)
al., 199NS3a-1 protein was similar to that of NS3 protein (data
not shown). As shown in Fig. 4, in vitro transformation
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137INTERNAL CLEAVAGE OF HCV NS3assay revealed that both NS3 and NS3a-1 have an on-
cogenic potential and, interestingly, NS3a-1 protein has a
twofold higher oncogenic activity than NS3 protein. Since
the relative expression level between pNS3 and pNS3a-1
is similar, this difference may be the result of their intrin-
sic oncogenic potential.
We have previously reported that the HCV core has
oncogenic potential which was proportional to the ex-
pression level of HCV core protein in Rat-1 cells (Chang
et al., 1998). Hence, we investigated the cooperative
ransformation between NS3 and core protein. Com-
ared to core alone, the coexpression of core and
S3a-1, but not of NS3, led to a statistically significant
ncrease of colony formation (P , 0.005 by Student’s t
test) (Fig. 4), demonstrating that NS3a-1 could increase
the oncogenic potential of core protein.
Although it was reported that NS3 and NS3DC(1027–
1459) were localized in both nucleus and cytoplasm, and
FIG. 4. The oncogenic potential of HCV NS3a-1. Each plasmid was
transfected into Rat-1 cells, and a total of 5 3 103 Rat-1 cells selected
y G418 treatment were used in a soft agar assay. The data are
xpressed as the percentage of colonies containing more than 200
ells, 2 weeks after plating. Colony numbers represent the means of
he three independent experiments and are indicated as numerical
alues. Error bars 5 SD.NS4A is reported to inhibit nuclear localization of NS3
(Muramatsu, et al., 1997), Ishido and Hotta (1998) dem-onstrated that p53, tumor-suppressor protein, formed a
complex with the N-terminus of NS3 (amino acids 1055
and 1200 residues) of HCV, both in the absence and the
presence of NS4A. On the basis of these observations, it
is possible to speculate that either NS3 or NS3a-1 pro-
tein may promote cell transformation through the inhibi-
tion of p53 function in cytoplasm.
In addition to the effect of NS3a-1 on the oncogenic
potential, it is possible that the internal cleavage of NS3
plays roles in virus replication. Our observation that the
internal cleavage sites reside in RNA helicase domain
suggests that autoproteolysis of NS3 could affect virus
replication by downregulating the quantity of intact RNA
helicase. Morgenstern and Thomson (1997) observed a
fivefold stimulation of protease activity when the C-ter-
minal helicase domain of NS3 was bound to poly(U). So,
HCV serine protease activity could be affected by the
internal cleavage at the carboxyl-terminus of NS3. Con-
sidering the importance of polyprotein processing of
NS3, it would be of interest to compare the catalytic
activity of the internally cleaved NS3 products and that of
the intact NS3 protein.
MATERIALS AND METHODS
Construction of plasmids
To construct expression vectors encoding NS3 (aa
1019–1657), NS34A (aa 1019–1711), and NS3-NS4-NS5
(aa 1019–3010), a cDNA fragment from HCV-1b (JS strain)
was used as a polymerase chain reaction (PCR) template
(Cho et al., 1998). NS3 sequences were amplified
with 59-GTAAAGCTTCATCTGACTAATACTACA-39 (sense
primer) and 59-CACGTCGACCTAAGTGACGACCTCCAG-
GTC-39 (antisense primer), and NS34A or NS345 se-
quences were amplified with sense primer used for
amplification of NS3 and antisense primers, 59-GAGGTC-
GACCTAGCACTCTTCCATTTCATC-39, or 59-GCTCTAGAT-
GCGGTTGGGGAGCAGGTA-39, respectively. The HindIII
and SalI, or HindIII and XbaI fragments of amplified DNA
fragments were subcloned into the pSK vector (Strat-
agene), and designated as pSK-NS3, pSK-NS34A, and
pSK-NS345, respectively. Using these intermediate plas-
mids, NS3-, NS34A-, and NS345-encoding DNA frag-
ments were introduced into the mammalian expres-
sion vector pCI-neo (Promega) and designated as
pNS3, pNS34A, and pNS345, respectively. To construct
pNS3a-1, NS3a-1 nucleotide sequences were amplified
from pNS3 using PCR with sense primer, 59-GTAAAGCT-
TCATCTGACTAATACTACA-39 and antisense primer, 59-
GTTCTAGATGGTCGGTATGACGGACACATC-39. An ampli-
fied DNA fragment was cloned into pCI-neo vector using
restriction enzymes, HindIII and XbaI. To construct
pNS4A, NS4A was amplified by PCR with following oli-
gonucleotides as primers: sense primer, 59-GGCCAT-
GGGAAGCAGTTGGGTGCTAGTAGGC-39 and antisense
primer, 59-GCTCTAGACGCACTCTTCCATTTCATCGAAC-
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138 YANG ET AL.39. The NcoI and XbaI fragment of the amplified DNA
fragment was subcloned to pCI-neo vector, and the re-
sulting plasmid was designated as pNS4A. To construct
pNS34A-K (aa 1019–1711), a cDNA fragment of HCV-1b (K
isolate) (Cho et al., 1993) was used as a PCR template.
NS34A nucleotide sequences of HCV-1b (K isolate)
were amplified with 59-CCGCCATGGAAGGGCAGGGGT-
GGCG-39 (sense primer) and antisense primer used for
amplification of NS4A, and the amplified DNA fragment
was subcloned to pCI-neo using restriction enzymes,
NcoI and XbaI.
To inactivate NS3 serine protease and generate SacII
site, Ser1164 and Ser1165 in NS3 region were mutated to Ala
and Ala in pSK-NS34A using specific primers (sense
primer, 59-TGAAGGGCGCCGCGGGTGGTC-39; antisense
primer, 59-GACCACCCGCGGCGCCCTTCA-39) and a
PCR-based site-directed mutagenesis kit (Stratagene).
The resulting PCR fragment was subcloned to pCI-neo
expression vector, and designated as pNS34A-M1. Site-
directed mutant, pNS34A-M1 was confirmed by digestion
of generated SacII site (underlined). The other 14 site-
directed mutants (from pNS34A-M2 to pNS34A-M15) with
two amino acid mutations were constructed according to
procedures previously described and confirmed by di-
gestion of generated SphI or XbaI site (underlined in
used primers). The oligonucleotide sequences of the
primers used for PCR-based site-directed mutagene-
sis were as follows: pNS34A-M2, 59-GCCGATGGTG-
GTGCATGCGGGGGCGCCTAC-39 (sense) and 59-GTA-
GGCGCCCCCGCATGCACCACCATCGGC-39 (antisense);
pNS34A-M3, 59-CTCAACTGACTCAGCATGCATCTTGGG-
CATTG-39 (sense) and 59-CAATGCCCACGCTGCATGCT-
GAGTCAGTTGAG-39 (antisense); pNS34A-M4, 59-GGA-
GACATCTCCCCGGGTGCCATTCCAAG-39 (sense) and
59-CTTGGAATGGCACCCGGGGAGATGTCTTCC-39 (anti-
sense); pNS34A-M5, 59-CTCATTTTCTGCCCCGGGA-
AGAAGAAGTCT-39 (sense) and 59-AGACTTCTTCTT-
CCCGGGGCAGAAAATGAG-39 (antisense); pNS34A-M6,
59-TGCCATTCCAAGCCCGGGTCTGACGAGCTC-39 (sense)
and 59-GAGCTCGTCAGACCCGGGCTTGGAATGGCA-39
(antisense); pNS34A-M7, 59-GGCGAGCTCGTCGCATGC-
CTTCTTGGAATG-39 (sense) and 59-CATTCCAAGAAG-
GCATGCGACGAGCTCGCC-39 (antisense); pNS34A-M8,
59-AAGAAGAAGTCTCCCGGGCTCGCCGCAAAG-39
(sense) and 59-CTTTGCGGCGAGCCCGGGAGACTTCT-
TCTT-39 (antisense); pNS34A-M9, 59-TCTGACGAGCTC-
CCCGGGAAGCTGTCAGCC-39 (sense) and 59-GGCTGA-
CAGCTTCCCGGGGAGCTCGTCAGA-39 (antisense); pNS34A-
M10, 59-CTCGCCGCAAAGCCCGGGGCCCTCGGACTT-39
(sense) and 59-AAGTCCGAGGGCCCCGGGCTTTGCGG-
CGAG-39 (antisense); pNS34A-M11, 59-CTCGCCGCA-
AAGGCATGCGCCCTCGGACTT-39 (sense) and 59-AAG-
TCCGAGGGCGCATGCCTTTGCGGCGAG-39 (antisense);
pNS34A-M12, 59-AAGCTGTCAGCCCCCGGGCTTAATGC-
TGTA-39 (sense) and 59-TACAGCATTAAGCCCGGGGGCT-
GACAGCTT-39 (antisense); pNS34A-M13, 59-GTCCGT-
(
0CATACCGGCATGCGGAGACGTCGTTG-39 (sense) and
59-CAACGACGTCTCCGCATGCCGGTATGACGGAC-39 (anti-
sense); pNS34A-M14, 59-CTATGACGCGGGCGCATGCT-
GGTATGAGCTC-39 (sense) and 59-GAGCTCATACCA-
GCATGCGCCCGCGTCATAG-39 (antisense); pNS34A-M15,
59-CACGCCTGCTGAGGCATGCGTTAGGTTGCGG-39 (sense)
and 59-CCGCAACCTAACGCATGCTCAGCAGGCGTG-39
(antisense).
Cells and DNA transfection
COS-7 cells and NIH3T3 cells, which were cultured in
DMEM with 10% fetal bovine serum, were transfected
with expression plasmids by CaPO4 coprecipitation
method as described previously (Lowy et al., 1978). Hu-
an hepatoblastoma HepG2 cells grown in DMEM with
0% fetal bovine serum were transfected with plasmid
NAs using a Lipofectin-mediated method according to
he manufacturer’s protocols (GIBCO BRL). Rat-1 cells
5 3 105 cells per 60-mm-diameter dish) were trans-
ected with 10 mg of pCI-neo, NS3-, or core-encoding
plasmids and cotransfected with combination of NS3-
encoding plasmids and pCI-neo-core K by CaPO4 copre-
ipitation method.
adiolabeling and immunoprecipitation
COS-7, NIH3T3, or HepG2 cells transfected with ex-
ression plasmids were radiolabeled with 100 mCi of
[35S]methionine (Dupont, NEN) for 4 h after a 1-h incuba-
ion in methionine and cysteine-free media. Labeled
ells were rinsed with cold phosphate-buffered saline
nd incubated with cold lysis buffer (50mM Tris–Cl, pH
.0; 150 mM NaCl; 0.02% sodium azide; 0.1% SDS; 100
mg/ml PMSF; 1 mg/ml aprotinin; 1% Nonidet-P40; 0.5%
sodium deoxycholate) on ice for 20 min. Cell lysates
were centrifuged at 12,000 g for 10 min at 4°C and
clarified lysates were incubated with pooled HCV-in-
fected human sera or antiprotease antibodies against
recombinant protein of the N-terminal portion of NS3 (aa
1027–1218) expressed E. coli on a rocker at 4°C over-
night. Pansorbin cells (Chemicon) containing protein A
were added and incubated under the same conditions
for 2 h. Beads were washed thoroughly with washing
buffer and resuspended in SDS–PAGE loading buffer.
Samples were heated at 100°C and resolved on SDS–
12% or SDS–12.5% polyacrylamide gels for analysis by
autoradiography.
Soft agar assay
Cell colonies harvested after G418 selection (400 mg/
l) for 10 days were tested for anchorage-independent
rowth in soft agar by a procedures described earlier
Chang et al., 1998). Briefly, G418-resistant colonies
more than 3000) were pooled, and media containing
.25% agarose (Sigma) were inoculated with 5 3 103
139INTERNAL CLEAVAGE OF HCV NS3cells. At 14 days of cultures, the number of colonies
(more than 200 cells) were counted.
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